Indications
Treatment of anemia associated with chronic renal failure in adult patients undergoing hemo-or peritoneal dialysis, or who are indicated for dialysis; in children undergoing hemodialysis.
Treatment of anemia in cancer patients (receiving or not receiving chemotherapy) with non-myeloid tumors.
Prevention of anemia in cancer patients with non-myeloid tumors receiving a long course of chemotherapy.
Treatment of anemia in HIV-infected patients receiving zidovudine therapy (with endogenous erythropoietin < 500 IU / ml).
As part of a pre-deposit program before extensive surgery in patients with a hematocrit level of 33-39%, to facilitate the collection of autologous blood and reduce the risk associated with the use of allogeneic blood transfusions (if the expected need for transfusion is higher than the amount that can be obtained without the use of epoetin alfa).
Before performing an extensive operation with an expected average blood loss (2-4 units or 900-1800 ml) in adult patients with mild or moderate anemia (hemoglobin >10 and ≤ 13 g/dl) to reduce the need for allogeneic blood transfusions and improve the recovery of erythropoiesis.
Reviews
There are no reviews yet